High materiality7/10
Collegium Pharmaceutical price target lowered to $48 from $56 at Barclays
Why it may matterVerify against the original reporting
Bullish given ample upside to price.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Barclays lowers COLL PT to 48; posted price 28.5; priceChangeSinceSignal: 0.84.
- Barclays lowers PT to 48; price 28.5; price +0.84 since signal.
Key facts
- 01
Target: $48
- 02
Posted price: $28.5
- 03
Analyst firm: Barclays
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.